PANTOPRAZOLE
Quality of Life
Midwestern Regional Medical CenterSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Quality of Life cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Orlistat University of California, Los Angeles | Phase 4 | BB |
Semaglutide University of California, Los Angeles | Phase 4 | BB |
Liraglutide University of California, Los Angeles | Phase 4 | BB |
Tirzepatide University of California, Los Angeles | Phase 4 | BB |
Nuvastatic Natureceuticals Sdn Bhd | Phase 3 | BB |
View all 24 →
Same molecule, other indications
PANTOPRAZOLE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →